VELIN-PHARMA A/S: Financial statements 2016
CVR: 33026013
Source: annual report 2016, Danish Business Authority
01/06/2015 – 31/05/2016
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 439,269 and a net result of DKK 1,107,624 compared with DKK 1,704,105 the year before. That is a decrease of 15.2% compared with the year before. Equity in the 2016 report amounted to DKK 20,638,859. The solvency ratio was 95.4%.
- Gross Profit
- DKK 439,269
- Profit/Loss
- DKK 1,107,624
- Equity
- DKK 20,638,859
- Total Assets
- DKK 21,630,921
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 439 t. | 1.1 mio. | 20.6 mio. | - |
| 2015 | - | 518 t. | 1.7 mio. | 19.5 mio. | - |
| 2014 | - | 299 t. | 2 mio. | 17.8 mio. | - |
| 2013 | - | 72 t. | 1.1 mio. | 15.9 mio. | - |
Official annual report
Find more companies like VELIN-PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.